Literature DB >> 33841616

Botulinum Toxin: An Effective Treatment for Flushing and Persistent Erythema in Rosacea.

Andres Luque1, Aida Paola Rojas1, Andrea Ortiz-Florez1, Juliana Perez-Bernal1.   

Abstract

Botulinum toxin has been used to treat persistent erythema and flushing in rosacea for several years. Here, we describe two women and one man, each with rosacea with flushing and permanent erythema refractory to conventional treatment, who achieved satisfactory and lasting results following intradermal application of botulinum toxin. Two different botulinum toxin types were used. Toxin concentrations of 3.75U per 0.1 mL (abobotulinum) and 1.25U per 0.1 mL (incobotulinum) were used for each patient were used for each patient. The outcomes were measured using polarized photography to evaluate the decrease in vascular involvement. In the three cases presented here, botulinum toxin was effective for controlling erythema and flushing associated with rosacea; we also observed a prolonged duration of these improvements without the rebound effect of topical therapies.
Copyright © 2020. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  Botulinum toxin; erythema; flushing; rosacea

Year:  2021        PMID: 33841616      PMCID: PMC8021409     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  23 in total

1.  Erythema in Skin Adjacent to Area of Long-term Brimonidine Treatment for Rosacea: A Novel Adverse Reaction.

Authors:  Ryan Gillihan; Tony Nguyen; Ryan Fischer; Anand Rajpara; Daniel Aires
Journal:  JAMA Dermatol       Date:  2015-10       Impact factor: 10.282

2.  Mesotherapy with Botulinum toxin for the treatment of refractory vascular and papulopustular rosacea.

Authors:  Jyotirmay Bharti; Sidharth Sonthalia; Deepak Jakhar
Journal:  J Am Acad Dermatol       Date:  2018-05-19       Impact factor: 11.527

3.  Rebound erythema and burning sensation from a new topical brimonidine tartrate gel 0.33%.

Authors:  Ethan T Routt; Jacob O Levitt
Journal:  J Am Acad Dermatol       Date:  2014-02       Impact factor: 11.527

Review 4.  Rosacea Pathogenesis.

Authors:  Christine S Ahn; William W Huang
Journal:  Dermatol Clin       Date:  2017-12-15       Impact factor: 3.478

Review 5.  Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors.

Authors:  Aimee M Two; Wiggin Wu; Richard L Gallo; Tissa R Hata
Journal:  J Am Acad Dermatol       Date:  2015-05       Impact factor: 11.527

6.  Botulinum toxin blocks mast cells and prevents rosacea like inflammation.

Authors:  Jae Eun Choi; Tyler Werbel; Zhenping Wang; Chia Chi Wu; Tony L Yaksh; Anna Di Nardo
Journal:  J Dermatol Sci       Date:  2018-12-28       Impact factor: 4.563

7.  A split-face study using botulinum toxin type B to decrease facial erythema index.

Authors:  Yu-Jin Oh; Na-Young Lee; Dong-Hye Suh; Jea-Sook Koh; Sang-Jun Lee; Min-Kyung Shin
Journal:  J Cosmet Laser Ther       Date:  2011-10       Impact factor: 2.247

8.  Impact of intradermal abobotulinumtoxinA on facial erythema of rosacea.

Authors:  Bradley S Bloom; Lea Payongayong; Andrea Mourin; David J Goldberg
Journal:  Dermatol Surg       Date:  2015-01       Impact factor: 3.398

9.  Botulinum toxin for the treatment of refractory erythema and flushing of rosacea.

Authors:  Kui Young Park; Moo Yeol Hyun; Se Yeong Jeong; Beom Joon Kim; Myeung Nam Kim; Chang Kwun Hong
Journal:  Dermatology       Date:  2015-03-03       Impact factor: 5.366

10.  Botulinum toxin for the treatment of facial flushing.

Authors:  Melanie Yuraitis; Carolyn I Jacob
Journal:  Dermatol Surg       Date:  2004-01       Impact factor: 3.398

View more
  3 in total

Review 1.  Insights on Skin Quality and Clinical Practice Trends in Asia Pacific and a Practical Guide to Good Skin Quality from the Inside Out.

Authors:  Je-Young Park; Jeng-Feng Chen; Hosung Choi; Wilson W S Ho; Ni Nyoman Indra Lesthari; Joyce Teng Ee Lim; Ting Song Lim; Stephen Lowe; Beverly Ong-Amoranto; Vasanop Vachiramon; Rungsima Wanitphakdeedecha; Martina Kerscher
Journal:  J Clin Aesthet Dermatol       Date:  2022-06

2.  Anatomical Exhortations of Botulinum Toxin Injections for Rosacea.

Authors:  Tamara Searle; Faisal R Ali; Firas Al-Niaimi
Journal:  J Clin Aesthet Dermatol       Date:  2022-04

3.  Role of Botulinum Toxin in the Management of Topical Corticosteroid Induced Rosacea Like Dermatitis: A Case Report.

Authors:  Saloni Katoch; Taranga N Barua; Khagendra N Barua
Journal:  Indian Dermatol Online J       Date:  2022-05-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.